This company has been marked as potentially delisted and may not be actively trading. Lianluo Smart (LLIT) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrendsBuy This Stock LLIT vs. BVS, CATX, INFU, NSPR, CTCX, TMDIF, HSAQ, RVP, PETV, and GBSShould you be buying Lianluo Smart stock or one of its competitors? The main competitors of Lianluo Smart include Bioventus (BVS), Perspective Therapeutics (CATX), InfuSystem (INFU), InspireMD (NSPR), Carmell (CTCX), Titan Medical (TMDIF), Health Sciences Acquisitions Co. 2 (HSAQ), Retractable Technologies (RVP), PetVivo (PETV), and GBS (GBS). These companies are all part of the "medical" sector. Lianluo Smart vs. Its Competitors Bioventus Perspective Therapeutics InfuSystem InspireMD Carmell Titan Medical Health Sciences Acquisitions Co. 2 Retractable Technologies PetVivo GBS Lianluo Smart (NASDAQ:LLIT) and Bioventus (NYSE:BVS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and dividends. Do analysts prefer LLIT or BVS? Bioventus has a consensus price target of $13.75, suggesting a potential upside of 94.21%. Given Bioventus' stronger consensus rating and higher possible upside, analysts clearly believe Bioventus is more favorable than Lianluo Smart.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lianluo Smart 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Bioventus 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Which has more volatility and risk, LLIT or BVS? Lianluo Smart has a beta of 0.16, indicating that its share price is 84% less volatile than the S&P 500. Comparatively, Bioventus has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Do institutionals & insiders hold more shares of LLIT or BVS? 28.8% of Lianluo Smart shares are held by institutional investors. Comparatively, 62.9% of Bioventus shares are held by institutional investors. 22.9% of Lianluo Smart shares are held by company insiders. Comparatively, 33.0% of Bioventus shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has stronger valuation & earnings, LLIT or BVS? Lianluo Smart has higher earnings, but lower revenue than Bioventus. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLianluo Smart$380K643.75-$4.45MN/AN/ABioventus$564.14M1.04-$156.23MN/AN/A Is LLIT or BVS more profitable? Lianluo Smart has a net margin of 0.00% compared to Bioventus' net margin of -7.11%. Bioventus' return on equity of 15.61% beat Lianluo Smart's return on equity.Company Net Margins Return on Equity Return on Assets Lianluo SmartN/A N/A N/A Bioventus -7.11%15.61%4.01% Does the media refer more to LLIT or BVS? In the previous week, Lianluo Smart's average media sentiment score of 0.00 equaled Bioventus'average media sentiment score. Company Overall Sentiment Lianluo Smart Neutral Bioventus Neutral SummaryBioventus beats Lianluo Smart on 9 of the 12 factors compared between the two stocks. Get Lianluo Smart News Delivered to You Automatically Sign up to receive the latest news and ratings for LLIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LLIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LLIT vs. The Competition Export to ExcelMetricLianluo SmartSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$244.63M$81.26M$5.73B$9.56BDividend YieldN/AN/A4.53%4.08%P/E RatioN/A11.0130.4625.16Price / Sales643.75104.26392.5787.62Price / CashN/A18.4137.0358.50Price / Book-187.537.408.956.21Net Income-$4.45M-$26.48M$3.26B$265.38M Lianluo Smart Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LLITLianluo SmartN/A$110.64+23.8%N/A+10,556.8%$244.63M$380K0.006BVSBioventus3.0905 of 5 stars$7.40+1.2%$13.75+85.9%-12.1%$606.22M$564.14M-12.101,200CATXPerspective Therapeutics1.5657 of 5 stars$3.97-0.3%$12.56+216.3%-77.2%$294.17MN/A0.0070Trending NewsAnalyst RevisionINFUInfuSystem3.0934 of 5 stars$9.15-2.9%$12.50+36.6%N/A$186.37M$139.89M152.09410NSPRInspireMD3.9981 of 5 stars$2.51-0.6%$4.50+79.6%-14.0%$104.51M$7.07M-3.3450CTCXCarmellN/A$2.21-15.3%N/A+204.0%$46.20M$32.84K0.0014TMDIFTitan MedicalN/A$0.37+2.3%N/A+693.2%$42.01M$17.63M-0.2950Gap DownHSAQHealth Sciences Acquisitions Co. 2N/A$2.72+7.9%N/A-58.9%$30.50MN/A0.004High Trading VolumeRVPRetractable Technologies1.9947 of 5 stars$0.81-0.4%N/A-12.2%$24.37M$33.75M-1.51240News CoverageShort Interest ↑PETVPetVivoN/A$0.80-5.7%N/A+58.9%$22.06M$1.05M-1.7820Gap DownGBSGBSN/A$1.44-5.3%N/A+27.8%$21.44MN/A-2.577 Related Companies and Tools Related Companies Bioventus Competitors Perspective Therapeutics Competitors InfuSystem Competitors InspireMD Competitors Carmell Competitors Titan Medical Competitors Health Sciences Acquisitions Co. 2 Competitors Retractable Technologies Competitors PetVivo Competitors GBS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LLIT) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lianluo Smart Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Lianluo Smart With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access